William T. Abraham

4 ta ish

The Ohio State University

1. How obesity affects the cut-points for B-type natriuretic peptide in the diagnosis of acute heart failure

   Lori B. Daniels, Paul Clopton, Vikas Bhalla +17

   Maqola20062 iqtibos

   ABIABI:AkademIndex/2026.other.295674

2. An individual patient meta-analysis of five randomized trials assessing the effects of cardiac resynchronization therapy on morbidity and mortality in patients with symptomatic heart failure

   John G.F. Cleland, William T. Abraham, Cecilia Linde +6

   Sharh maqola20132 iqtibos

   ABIABI:AkademIndex/2026.other.295754

3. Long-term impact of cardiac resynchronization therapy in mild heart failure: 5-year results from the REsynchronization reVErses Remodeling in Systolic left vEntricular dysfunction (REVERSE) study

   Cecilia Linde, Michael R. Gold, William T. Abraham +5

   Maqola20132 iqtibos

   ABIABI:AkademIndex/2026.other.295771

4. Bedside B-Type natriuretic peptide in the emergency diagnosis of heart failure with reduced or preserved ejection fraction

   Alan S. Maisel, James McCord, Richard M. Nowak +17

   Maqola20032 iqtibos

   ABIABI:AkademIndex/2026.other.295779